"The Check-Cap device offers the exciting possibility of polyp imaging without bowel preparation. If effective, Check-Cap could be a breakthrough screening alternative for the many patients who are unwilling or unable to undergo colonoscopy."
- Dr. Douglas Rex, Chancellor's Professor and Professor of Medicine at Indiana University School of Medicine and Director of Endoscopy at Indiana University Hospital in Indianapolis. Dr. Rex is a full-time clinical gastroenterologist at Indiana University Hospital.
"Check-Cap appears to be a more patient-friendly way of screening for colon cancer - patients don't like taking bowel preparation so Check-Cap's prep-free technology will likely be a welcome change. When Check-Cap becomes available, I would expect to see greater numbers of people getting screened. This will enable us GI's to perform more therapeutic colonoscopies, thereby allowing us to more effectively meet the needs of many more patients and hopefully save more lives."
- Dr. Brian Saunders, Consultant Gastroenterologist and Chief of Endoscopy, Wolfson Unit for Endoscopy (OMED - World Centre of excellence) St. Mark's Hospital, London, United Kingdom and Honorary Senior Lecturer in Endoscopy, Imperial College, London.
"Check-Cap's prep-free, non-invasive technology meets the real need for colon cancer screening that's easy for patients. Patients are often hesitant to undergo colonoscopy due to the preparation, sedation, general discomfort and potential risks. Prep and occasionally discomfort are also issues with CTC. If further studies demonstrate that Check-Cap is an accurate screening modality for colon cancer and polyps, then the Check-Cap system will be a viable testing alternative, allowing the screening of patients in greater numbers and the use of fewer resources compared with CTC and Colonoscopy."
- Oscar Lebwohl, M.D., Clinical Professor of Medicine at Columbia University College of Physicians and Surgeons.
"The Check-Cap novel imaging technology has been proven to be safe and feasible in our preliminary clinical experience. It has successfully demonstrated imaging of prep-less human colon at ultra-low dose compared to existing X-Ray based modalities. These results underpin the great potential of Check-Cap imaging technology to become a very appealing tool for screening of pre-cancerous polyps and colorectal cancer."
- Professor Nadir Arber, Holder of the Yechiel and Helen Lieber chair for Cancer Research at Tel Aviv Sourasky Medical Center and Tel Aviv University, Sackler School of Medicine. Prof. Arber serves as the Director of the Integrated Cancer Prevention Center (ICPC) at Tel Aviv Sourasky Medical Center in Tel Aviv. Prof. Arber is the Head of Cancer Research Center, Head of Djerassi Oncology Center, and President of the Israeli Association of Gastroenterology.